PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Section of Virology, Department of Infectious Disease, Imperial College London, United Kingdom; Centre for Haematology, Department of Infection and Inflammation, Imperial College London, United Kingdom. Electronic address: a.rowan@imperial.ac.uk.\', \'Centre for Haematology, Department of Infection and Inflammation, Imperial College London, United Kingdom; Developmental Disorders, South East Genomics Laboratory Hub, Guy\'s and St Thomas\' NHS Trust, United Kingdom.\', \'Section of Virology, Department of Infectious Disease, Imperial College London, United Kingdom.\', \'Section of Immunology of Infection, Department of Infectious Disease, Imperial College London, United Kingdom.\', \'London Biofoundry, Imperial College Translation and Innovation Hub, Imperial College London, United Kingdom; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, United Kingdom; UK Dementia Research Institute Care Research and Technology Centre, Imperial College London and the University of Surrey, United Kingdom.\', \'London Biofoundry, Imperial College Translation and Innovation Hub, Imperial College London, United Kingdom; Section of Structural and Synthetic Biology, Department of Infectious Disease, Imperial College London, United Kingdom.\', \'Division of Infection and Immunity, University College London, United Kingdom.\', \'North West London Pathology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, United Kingdom.\', \'Section of Virology, Department of Infectious Disease, Imperial College London, United Kingdom. Electronic address: g.p.taylor@imperial.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0166-0934(21)00113-010.1016/j.jviromet.2021.114174
?:hasPublicationType
?:journal
  • Journal of virological methods
is ?:pmid of
?:pmid
?:pmid
  • 33984396
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.858
?:rankingScore_hIndex
  • 88
?:title
  • Optimized protocol for a quantitative SARS-CoV-2 duplex RT-qPCR assay with internal human sample sufficiency control.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33984396>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33984396>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all